
🔬 Core Difference
Mounjaro (tirzepatide) → Dual action (GLP-1 + GIP)
Ozempic (semaglutide) → Single action (GLP-1 only)
📊 Head-to-head comparison
1. Blood sugar (HbA1c)
- Mounjaro reduces HbA1c more than Ozempic
- Example: ~–1.3% vs –0.9% in real-world data
- Clinical trials also show slightly greater reduction with tirzepatide
✅ Winner: Mounjaro
2. Weight loss
- Mounjaro causes significantly more weight loss
- Example:
- ~10.2 kg vs 6.1 kg
- Up to 47% greater weight loss in trials
✅ Clear winner: Mounjaro
3. Mechanism advantage
- Mounjaro → Works on two hormones (GLP-1 + GIP) → stronger appetite suppression & insulin response
- Ozempic → Only GLP-1
✅ Advantage: Mounjaro
4. Side effects
- Very similar:
- Nausea
- Vomiting
- Diarrhea
- No major safety difference overall
⚖️ Tie
5. Cost & availability (India context)
- Ozempic → usually more available / cheaper
- Mounjaro → costlier, newer drug
✅ Winner: Ozempic
6. Cardiovascular evidence
- Semaglutide (Ozempic/Wegovy) has strong CV outcome data
- Tirzepatide data is emerging
✅ Slight edge: Ozempic (for CV risk patients)
🧠 Final Practical Verdict
| Situation | Better Option |
|---|---|
| Maximum weight loss | Mounjaro |
| Strongest HbA1c reduction | Mounjaro |
| Budget / availability | Ozempic |
| Proven heart protection | Ozempic |
| First-time GLP-1 use | Either (depends on cost) |
💡 My clinical take (important)
- If affordable → Mounjaro is superior overall
- If cost-sensitive → Ozempic is still excellent
- Both are far better than older drugs
